tuneswitch1
About
Intrathecal trastuzumab: immunotherapy increases the diagnosis regarding leptomeningeal metastases throughout HER-2+ cancers of the breast affected individual.
Intrathecal trastuzumab: immunotherapy increases the diagnosis regarding leptomeningeal metastases throughout HER-2+ cancers of the breast affected individual.